2 completed, 1 terminated, 1 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Biotin: new trials by email Literature Review of Biotin trials Research Report on Biotin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma Placebo, L-Carnitine 500Mg Oral Tablet, Biotin Capsules - Moderate Persistent Asthma | Phase 3 | Unknown | Tanta University | 66 | 2022-08-08 | 2022-11-30 |
| Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) MD1003 100mg capsule, PLACEBO - Multiple Sclerosis | Phase 3 | Terminated | MedDay Pharmaceuticals SA | 642 | 2016-12-01 | 2020-11-23 |
| MD1003-AMN MD1003 in Adrenomyeloneuropathy MD1003 100 mg capsule, Placebo - Adrenomyeloneuropathy, Adrenoleukodystrophy | Phase 2 / Phase 3 | Completed | MedDay Pharmaceuticals SA | 67 | 2014-10-01 | 2017-10-09 |
| Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss Fragmin P Forte (dalteparin sodium), Multivitamin supplement - Abortion, Habitual | Phase 3 | Completed | University of Jena | 449 | 2006-11-01 | 2014-09-17 |
Abortion, Habitual (1) · Adrenoleukodystrophy (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1)
MedDay Pharmaceuticals SA (2) · Tanta University (1) · University of Jena (1)
Germany (3) · Spain (2) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Egypt (1) · France (1) · Hungary (1) · Italy (1) · Poland (1) · Sweden (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Bruce Cree, MD, PHD (1) · Ekkehard Schleussner, Prof. Dr. (1) · Frederic Sedel, MD (1) · Frederic Sedel, MD, PHD (1) · Patrick Aubourg, MD (1)
PMID 25938990, PMID 27418639, PMID 33222767, PMID 33779986, PMID 42712237